Please login to the form below

Not currently logged in
Email:
Password:

Pfizer files suit against Merck

Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US

Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US.

According to the Wall Street Journal, Pfizer has filed a patent-infringement lawsuit against Merck, known as MSD outside the US and Canada, to block the drug's introduction for five years.

Cholesterol-lowering drug, Lipitor (atorvastatin), is one of Pfizer's biggest selling medicines and its patent is due to expire in the US by the end of November, 2011.

Merck is aiming to combine a generic version of Lipitor with its Zetia (ezetimibe) product, which also lowers cholesterol but by a different mechanism to Lipitor.

Both Ranbaxy Laboratories and Watson Laboratories are to launch a generic atorvastatin product on November 30, 2011, but Pfizer still holds some patents for Lipitor that do not expire for several years on which it is basing the Merck lawsuit.

13th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics